Abstract
ABCG2 is a half-transporter which causes multidrug resistance when overexpressed in tumor cells. Availability of combined localization and functional assays would greatly improve cell biology and drug modulation studies for this transporter. Here we demonstrate that an N-terminally GFP-tagged version of the protein (GFP-G2) can be used to directly monitor ABCG2 expression, dimerization, localization and function in living cells. GFP-G2 is fully functional when tested for drug-stimulated ATPase activity, vesicular transport assay, subcellular localization or cell surface epitope conformational changes. By measuring both GFP and Hoechst 33342 dye fluorescence in HEK-293 cells, we provide evidence that a real-time transport assay can be reliably applied to identify ABCG2 substrates, transport modulators, as well as to monitor the cellular functions of this multidrug transporter protein. This approach also avoids the need of cloning, drug selection or other further separation or characterization of the transgene-expressing cells.
References
Apr 1, 1996·British Journal of Cancer·L HomolyaB Sarkadi
Apr 4, 1998·BioTechniques·R H StauberG N Pavlakis
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Jul 5, 2001·Biochemical and Biophysical Research Communications·C OzvegyB Sarkadi
Sep 5, 2001·Nature Medicine·S ZhouB P Sorrentino
Jan 10, 2002·Blood·Christian W ScharenbergBeverly Torok-Storb
Mar 22, 2002·The Lancet Oncology·H Lage, M Dietel
Oct 11, 2002·The Journal of Biological Chemistry·Csilla OzvegyBalázs Sarkadi
Oct 24, 2002·Blood·Brian L AbbottBrian P Sorrentino
Apr 2, 2003·The Journal of Biological Chemistry·Tavan JanvilisriHendrik W van Veen
Nov 24, 2004·The Journal of Biological Chemistry·Csilla Ozvegy-LaczkaBalázs Sarkadi
Jan 27, 2005·Biochimica Et Biophysica Acta·Csilla Ozvegy-LaczkaAndrás Váradi
Apr 20, 2005·Pharmaceutical Research·Tappei TakadaYuichi Sugiyama
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·P Krishnamurthy, J D Schuetz
Oct 4, 2006·Physiological Reviews·Balázs SarkadiAndrás Váradi
Mar 10, 2007·The Journal of Pharmacology and Experimental Therapeutics·A PálP Krajcsi
May 17, 2007·Current Drug Metabolism·Cindy Q XiaLiang-Shang Gan
Jul 31, 2007·Biochimica Et Biophysica Acta·Agnes TelbiszBalázs Sarkadi
Citations
Aug 21, 2009·Biochemistry·Yue-xian HouXiu-bao Chang
Nov 6, 2012·The Journal of Biological Chemistry·Tufan GökirmakAmro Hamdoun
Mar 5, 2011·Mobile DNA·Orsolya KolacsekTamás I Orbán
Feb 2, 2011·PloS One·Vicky Goler-Baron, Yehuda G Assaraf
Jan 13, 2009·Advanced Drug Delivery Reviews·Csilla HegedusBalázs Sarkadi
Mar 28, 2012·Biochemical and Biophysical Research Communications·Csilla HegedüsBalázs Sarkadi
Aug 10, 2010·Biochimica Et Biophysica Acta·László HomolyaBalázs Sarkadi
Jun 22, 2012·Molecular Membrane Biology·Christian RoosFrank Bernhard
Jul 17, 2014·Drug Discovery Today. Technologies·Elena L RudashevskayaPeter Chiba
Sep 17, 2008·Biochimica Et Biophysica Acta·Agota ApátiBalázs Sarkadi
May 27, 2016·PloS One·Zoltán Hegyi, László Homolya
Apr 13, 2018·PloS One·Zsuzsa ErdeiÁgota Apáti
Sep 23, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuki IkebuchiHiroshi Suzuki
Jan 14, 2020·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Maryam Yousaf, Moazzam Ali
Feb 27, 2021·Frontiers in Cell and Developmental Biology·Zsuzsa Bartos, László Homolya
Mar 7, 2021·International Journal of Molecular Sciences·Yu ToyodaBlanka Stiburkova
Apr 4, 2021·International Journal of Molecular Sciences·László Homolya
Aug 7, 2021·Genes·Anita SchambergerTamás I Orbán